Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Avram Fraint,1 Padmaja Vittal,2 Cynthia Comella2 1Department of Neurological Sciences, 2Section of Movement Disorders, Rush University Medical Center, Chicago, IL, USA Introduction: Botulinum toxin (BoNT) is the treatment of choice for many neurologic movement disorders, including blepharospasm, hem...

Full description

Saved in:
Bibliographic Details
Main Authors: Fraint A (Author), Vittal P (Author), Comella C (Author)
Format: Book
Published: Dove Medical Press, 2016-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available